Evidence map›Paper›PMID 21556774›Full record

ArticleMolecular biology reports2012

AP-2β enhances p53-mediated transcription of the αB-crystallin gene through stabilizing p53.

Xiang Hu, Lin Wang, Wei Sun, Ling Xiao, Yuan Wu, Yiming Zhuo, Dongsong Nie, Jianlin Zhou, Jian Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiang HuKey Laboratory of Protein Chemistry and Developmental Biology of MOE, College of Life Science, Hunan Normal University, Changsha, 410081, China.
Lin Wang
Wei Sun
Ling Xiao
Yuan Wu
Yiming Zhuo
Dongsong Nie
Jianlin Zhou
Jian Zhang
Hunan Normal University · CNHunan Institute of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The αB-crystallin (CRYAB) is a member of the small heat shock protein family that can be induced by various stresses and pathological conditions. Aberrant expression of CRYAB has been shown to be associated with several neurological diseases and malignant neoplasms. To identify transcriptional regulators of CRYAB expression, we examined its promoter for binding sites of transcription factors and identified four potential AP-2 binding sites in addition to a p53 binding site reported previously. Although the CRYAB promoter contains four consensus binding sequences of AP-2 and can be activated by AP-2α either in the presence or absence of p53, the luciferase assay showed that AP-2β alone does not regulate the activity of the CRYAB promoter in the absence of p53. However, in the presence of p53, AP-2β can significantly increase the luciferase activities of both the CRYAB promoter and reporter vector pp53-TA-luc, which contains a p53-responsive element, but no AP-2 binding sites. These data suggest that AP-2β enhances transactivation of p53 and regulates CRYAB transcription via p53. Further study demonstrated that AP-2β interacts with p53 and augments its protein stability. Taken together, our results indicate that AP-2β up-regulates the transcription of the CRYAB gene through stabilizing p53.

Indexed as

alpha-Crystallin B ChainBinding SitesBlotting, WesternCell LineGene Expression RegulationGenetic VectorsHumansImmunoprecipitationLuciferasesPromoter Regions, GeneticTranscription Factor AP-2Transcription, GeneticTumor Suppressor Protein p53alpha-Crystallin B ChainLuciferasesTranscription Factor AP-2Tumor Suppressor Protein p53

Identifiers

PMID21556774
OpenAlexW2001186633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.